טוען...

Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed as the causative virus of COVID-19 disease, which is currently a worldwide pandemic. Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is one of the most potent chemical compounds proposed to treat COVID-19...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Heliyon
Main Authors: Jordaan, Maryam A., Ebenezer, Oluwakemi, Damoyi, Nkululeko, Shapi, Michael
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2020
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7418767/
https://ncbi.nlm.nih.gov/pubmed/32802982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2020.e04642
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!